2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine

C166H183N25O3S — CID 159717339

IUPAC2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine
SMILESCO[C@@H](CN1CCC(c2cc(-c3ccc(C)cc3)nn2-c2ncccn2)CC1)c1ccccc1.Cc1ccc(-c2cc(C3CCN(C4CCN(S(C)(=O)=O)C4)CC3)n(-c3ccccc3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccc3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccn3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccn3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ncccn3)n2)cc1
InChIInChI=1S/C29H31N3.C28H31N5O.2C28H30N4.C27H29N5.C26H32N4O2S/c1-23-12-14-25(15-13-23)28-22-29(32(30-28)27-10-6-3-7-11-27)26-17-20-31(21-18-26)19-16-24-8-4-2-5-9-24;1-21-9-11-22(12-10-21)25-19-26(33(31-25)28-29-15-6-16-30-28)23-13-17-32(18-14-23)20-27(34-2)24-7-4-3-5-8-24;2*1-22-10-12-24(13-11-22)26-21-27(32(30-26)28-9-5-6-17-29-28)25-15-19-31(20-16-25)18-14-23-7-3-2-4-8-23;1-21-8-10-23(11-9-21)25-20-26(32(30-25)27-28-15-5-16-29-27)24-13-18-31(19-14-24)17-12-22-6-3-2-4-7-22;1-20-8-10-21(11-9-20)25-18-26(30(27-25)23-6-4-3-5-7-23)22-12-15-28(16-13-22)24-14-17-29(19-24)33(2,31)32/h2-15,22,26H,16-21H2,1H3;3-12,15-16,19,23,27H,13-14,17-18,20H2,1-2H3;2*2-13,17,21,25H,14-16,18-20H2,1H3;2-11,15-16,20,24H,12-14,17-19H2,1H3;3-11,18,22,24H,12-17,19H2,1-2H3/t;27-;;;;/m.0..../s1
InChIKeyMZPFTUIKGDYCOP-ASVPMHMXSA-N
MW2608.53 g/mol
LogP31.93
Rot. Bonds36

About 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine

2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine (PubChem CID 159717339) has the molecular formula C166H183N25O3S and a molecular weight of 2608.53 g/mol. Its IUPAC name is 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine.

Molecular Properties

Compound Name2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine
PubChem CID159717339
Molecular FormulaC166H183N25O3S
Molecular Weight2608.53 g/mol
Exact Mass2606.47
IUPAC Name2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine
SMILESCO[C@@H](CN1CCC(c2cc(-c3ccc(C)cc3)nn2-c2ncccn2)CC1)c1ccccc1.Cc1ccc(-c2cc(C3CCN(C4CCN(S(C)(=O)=O)C4)CC3)n(-c3ccccc3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccc3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccn3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccn3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ncccn3)n2)cc1
InChIInChI=1S/C29H31N3.C28H31N5O.2C28H30N4.C27H29N5.C26H32N4O2S/c1-23-12-14-25(15-13-23)28-22-29(32(30-28)27-10-6-3-7-11-27)26-17-20-31(21-18-26)19-16-24-8-4-2-5-9-24;1-21-9-11-22(12-10-21)25-19-26(33(31-25)28-29-15-6-16-30-28)23-13-17-32(18-14-23)20-27(34-2)24-7-4-3-5-8-24;2*1-22-10-12-24(13-11-22)26-21-27(32(30-26)28-9-5-6-17-29-28)25-15-19-31(20-16-25)18-14-23-7-3-2-4-8-23;1-21-8-10-23(11-9-21)25-20-26(32(30-25)27-28-15-5-16-29-27)24-13-18-31(19-14-24)17-12-22-6-3-2-4-7-22;1-20-8-10-21(11-9-20)25-18-26(30(27-25)23-6-4-3-5-7-23)22-12-15-28(16-13-22)24-14-17-29(19-24)33(2,31)32/h2-15,22,26H,16-21H2,1H3;3-12,15-16,19,23,27H,13-14,17-18,20H2,1-2H3;2*2-13,17,21,25H,14-16,18-20H2,1H3;2-11,15-16,20,24H,12-14,17-19H2,1H3;3-11,18,22,24H,12-17,19H2,1-2H3/t;27-;;;;/m.0..../s1
InChIKeyMZPFTUIKGDYCOP-ASVPMHMXSA-N
XLogP31.93
TPSA250.31 Ų
H-Bond Donors
H-Bond Acceptors27
Rotatable Bonds36
Heavy Atoms195
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002608.53
LogP ≤ 531.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1027

Analyze 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)-1,2,4-triazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine
CID 160454214
tert-butyl (2R,5R)-5-[3-(4-methylphenyl)-1-pyrimidin-2-ylpyrazol-5-yl]-2-(2-phenylethyl)piperidine-1-carboxylate;methane;N-methyl-5-[3-(4-methylphenyl)-1-pyrimidin-2-ylpyrazol-5-yl]-2-phenylpiperidine-1-carboxamide;2-[3-(4-methylphenyl)-5-[(3R,6R)-6-(2-phenylethyl)piperidin-3-yl]pyrazol-1-yl]pyrimidine;(2S,5S)-2-[3-(4-methylphenyl)-1-pyrimidin-2-ylpyrazol-5-yl]-5-(2-phenylethyl)morpholine;(2S,5S)-2-[5-(4-methylphenyl)-2-pyrimidin-2-yl-1,2,4-triazol-3-yl]-5-(2-phenylethyl)morpholine
CID 161045778
4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine
CID 163965480
N,N-dimethyl-2-[4-[2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxyethyl]pyrazol-1-yl]ethanamine;N,N-dimethyl-1-[1-[2-[2-(1-methylpyrazol-4-yl)ethoxy]-6-morpholin-4-ylpyrimidin-4-yl]-3-phenylpyrazol-5-yl]methanamine;3-hydroxy-3-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]propanenitrile;4-[6-[3-(methoxymethyl)-5-phenylpyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[2-[methoxy(phenyl)methyl]-6-(3-phenylpyrazol-1-yl)pyrimidin-4-yl]morpholine
CID 164147460
9-[[4-(6-aminopyrimidin-4-yl)phenyl]methyl]-7-methyl-2-(2-propan-2-ylphenyl)purin-8-one;9-[[4-(6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-3-yl)phenyl]methyl]-7-methyl-2-(2-propan-2-ylphenyl)purin-8-one;9-[[4-[4-[2-(dimethylamino)ethyl]phenyl]phenyl]methyl]-7-methyl-2-(2-propan-2-ylphenyl)purin-8-one;ethoxyethane;7-methyl-9-[[4-(1-methylpyrrol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one
CID 167686290

Frequently Asked Questions

What is the IUPAC name of 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine?
The IUPAC name of 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine (CID 159717339) is 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine.
What is the SMILES notation for 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine?
The canonical SMILES for 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine is CO[C@@H](CN1CCC(c2cc(-c3ccc(C)cc3)nn2-c2ncccn2)CC1)c1ccccc1.Cc1ccc(-c2cc(C3CCN(C4CCN(S(C)(=O)=O)C4)CC3)n(-c3ccccc3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccc3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccn3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ccccn3)n2)cc1.Cc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)n(-c3ncccn3)n2)cc1.
What is the InChIKey of 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine?
The InChIKey is MZPFTUIKGDYCOP-ASVPMHMXSA-N. The full InChI is InChI=1S/C29H31N3.C28H31N5O.2C28H30N4.C27H29N5.C26H32N4O2S/c1-23-12-14-25(15-13-23)28-22-29(32(30-28)27-10-6-3-7-11-27)26-17-20-31(21-18-26)19-16-24-8-4-2-5-9-24;1-21-9-11-22(12-10-21)25-19-26(33(31-25)28-29-15-6-16-30-28)23-13-17-32(18-14-23)20-27(34-2)24-7-4-3-5-8-24;2*1-22-10-12-24(13-11-22)26-21-27(32(30-26)28-9-5-6-17-29-28)25-15-19-31(20-16-25)18-14-23-7-3-2-4-8-23;1-21-8-10-23(11-9-21)25-20-26(32(30-25)27-28-15-5-16-29-27)24-13-18-31(19-14-24)17-12-22-6-3-2-4-7-22;1-20-8-10-21(11-9-20)25-18-26(30(27-25)23-6-4-3-5-7-23)22-12-15-28(16-13-22)24-14-17-29(19-24)33(2,31)32/h2-15,22,26H,16-21H2,1H3;3-12,15-16,19,23,27H,13-14,17-18,20H2,1-2H3;2*2-13,17,21,25H,14-16,18-20H2,1H3;2-11,15-16,20,24H,12-14,17-19H2,1H3;3-11,18,22,24H,12-17,19H2,1-2H3/t;27-;;;;/m.0..../s1.
What are the key properties of 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine?
2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine has a molecular weight of 2608.53 g/mol, XLogP of 31.93, 36 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5-[1-[(2R)-2-methoxy-2-phenylethyl]piperidin-4-yl]-3-(4-methylphenyl)pyrazol-1-yl]pyrimidine;bis(2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyridine);2-[3-(4-methylphenyl)-5-[1-(2-phenylethyl)piperidin-4-yl]pyrazol-1-yl]pyrimidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(1-methylsulfonylpyrrolidin-3-yl)piperidine;4-[3-(4-methylphenyl)-1-phenylpyrazol-5-yl]-1-(2-phenylethyl)piperidine is sourced from PubChem (CID 159717339), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).